SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-026968
Filing Date
2023-08-07
Accepted
2023-08-07 08:09:49
Documents
16
Period of Report
2023-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 68933
2 ex3-1.htm EX-3.1 50311
3 ex10-1.htm EX-10.1 346771
4 ex99-1.htm EX-99.1 15021
5 ex99-1_001.jpg GRAPHIC 8972
  Complete submission text file 0001493152-23-026968.txt   740076

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20230807.xsd EX-101.SCH 3018
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20230807_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20230807_pre.xml EX-101.PRE 22361
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3430
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 231145723
SIC: 2834 Pharmaceutical Preparations